[1] | W. Y. Lau, Management of hepatocellular carcinoma. J R Coll Surg Edinb 47 (2002) 389-99 |
[2] | T. A. Ahles, A. J. Saykin, C. T. Furstenberg, B. Cole, L. A. Mott, K. Skalla, M. B. Whedon, S. Bivens, T. Mitchell, E. R. Greenberg, and P. M. Silberfarb, Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20 (2002) 485-93 |
[3] | H. M. Cheng, and M. C. Tsai, Regression of hepatocellular carcinoma spontaneous or herbal medicine related? Am J Chin Med 32 (2004) 579-85 |
[4] | Raymond M. Hozalski, William A. Arnold, , Chanlan Chun, Timothy M. LaPara, Jeong-Yub Lee, Carrie R. Pearson, and , Ping Zhang, Degradation of Halogenated Disinfection Byproducts in Water Distribution Systems., ACS Symposium Series, USA, 2008 |
[5] | H. J. Clewell, and M. E. Andersen, Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene. Crit Rev Toxicol 34 (2004) 385-445 |
[6] | R. Lumaret, and N. Ouazzani, Plant genetics. Ancient wild olives in Mediterranean forests. Nature 413 (2001) 700 |
[7] | E. Waterman, and B. Lockwood, Active components and clinical applications of olive oil. Altern Med Rev 12 (2007) 331-42 |
[8] | F. Visioli, A. Poli, and C. Gall, Antioxidant and other biological activities of phenols from olives and olive oil. Med Res Rev 22 (2002) 65-75 |
[9] | R. Fabiani, A. De Bartolomeo, P. Rosignoli, M. Servili, G. F. Montedoro, and G. Morozzi, Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis. Eur J Cancer Prev 11 (2002) 351-8 |
[10] | H. K. Hamdi, and R. Castellon, Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem Biophys Res Commun 334 (2005) 769-78 |
[11] | R. W. Owen, A. Giacosa, W. E. Hull, R. Haubner, B. Spiegelhalder, and H. Bartsch, The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. Eur J Cancer 36 (2000) 1235-47 |
[12] | M. Kaibori, Y. Matsui, H. Yanagida, N. Yokoigawa, A. H. Kwon, and Y. Kamiyama, Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma. World J Surg 28 (2004) 702-7 |
[13] | A. S. Befeler, and A. M. Di Bisceglie, Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122 (2002) 1609-19 |
[14] | P. L. Alo, P. Visca, A. Marci, A. Mangoni, C. Botti, and U. Di Tondo, Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 77 (1996) 474-82 |
[15] | P. L. Alo, P. Visca, G. Trombetta, A. Mangoni, L. Lenti, S. Monaco, C. Botti, D. E. Serpieri, and U. Di Tondo, Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 85 (1999) 35-40 |
[16] | Y. Wang, F. P. Kuhajda, J. N. Li, E.S. Pizer, W. F. Han, L. J. Sokoll, and D. W. Chan, Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett 167 (2001) 99-104 |
[17] | A. Rashid, E. S. Pizer, M. Moga, L. Z. Milgraum, M. Zahurak, G. R. Pasternack, F. P. Kuhajda, and S. R. Hamilton, Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 150 (1997) 201-8 |
[18] | M. S. Shurbaji, J. H. Kalbfleisch, and T. S. Thurmond, Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol 27 (1996) 917-21 |
[19] | T. S. Gansler, W. Hardman, 3rd, D. A. Hunt, S. Schaffel, and R.A. Hennigar, Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 28 (1997) 686-92 |
[20] | E. S. Pizer, S. F. Lax, F. P. Kuhajda, G. R. Pasternack, and R. J. Kurman, Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer 83 (1998) 528-37 |
[21] | J. R. Mead, S. A. Irvine, and D. P. Ramji, Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 80 (2002) 753-69 |
[22] | R. W. Clark, and R. C. Crain, Characterization of Alterations in Plasma Lipoprotein Lipid and Apoprotein Profiles Accompanying Hepatoma-Induced Hyperlipidemia in Rats. Cancer Res 46 (1986) 1894-1903 |
[23] | R. D. Sanderson, Y. Yang, L. J. Suva, and T. Kelly, Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis. Matrix Biol 23 (2004) 341-52 |
[24] | N. M. Abdel-Hamid, Recent insights on risk factors of hepatocellular carcinoma. World J Hepatol 1 (2009) 3-7 |
[25] | N. M. Abdel-Hamid, and M. A. Morsy, Novel biochemical pathways for 5-Fluorouracil in managing experimental hepatocellular carcinoma in rats. J Membr Biol 234 (2010) 29-34 |
[26] | E. J. Joo, G. B. ten Dam, T. H. van Kuppevelt, T. Toida, R. J. Linhardt, and Y. S. Kim, Nucleolin: acharan sulfate-binding protein on the surface of cancer cells. Glycobiology 15 (2005) 1-9 |
[27] | G. Milano, and A. L. Chamorey, Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharm- acokinetics. Chronobiol Int 19 (2002) 177-89 |
[28] | M. Y. Hung, T. Y. Fu, P. H. Shih, C. P. Lee, and G. C. Yen, Du-Zhong (Eucommia ulmoides Oliv.) leaves inhibits CCl4-induced hepatic damage in rats. Food Chem Toxicol 44 (2006) 1424-31 |
[29] | C. M. Bender, S. M. Sereika, S. L. Berga, V. G. Vogel, A. M. Brufsky, K. K. Paraska, and C. M. Ryan, Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15 (2006) 422-30 |
[30] | G. Winocur, J. Vardy, M. A. Binns, L. Kerr, and I. Tannock, The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 85 (2006) 66-75 |
[31] | L. Tao, S. Yang, M. Xie, P. M. Kramer, and M. A. Pereira, Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun and c-Myc protooncogenes in mouse liver: prevention by methionine. Toxicol Sci 54 (2000) 399-407 |
[32] | S. R. Channel, J. R. Latendresse, J. K. Kidney, J. H. Grabau, J. W. Lane, L. Steel-Goodwin, and M.C. Gothaus, A subchronic exposure to trichloroethylene causes lipid peroxidation and hepatocellular proliferation in male B6C3F1 mouse liver. Toxicol Sci 43 (1998) 145-54 |
[33] | C. Dees, and C. Travis, Trichloroacetate stimulation of liver DNA synthesis in male and female mice. Toxicol Lett 70 (1994) 343-55 |
[34] | J. L. Larson, and R. J. Bull, Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol Appl Pharmacol 115 (1992) 268-77 |
[35] | J. A. Styles, I. Wyatt, and C. Coutts, Trichloroacetic acid: studies on uptake and effects on hepatic DNA and liver growth in mouse. Carcinogenesis 12 (1991) 1715-9 |
[36] | S. Rietman, and S. Frankle, A Colorimetric Method for Determination of Serum Glutamic Oxaloacetic and Glutamic Pyruvic Transaminases. Am. J. Clin. Path 28 (1957) |
[37] | N. Gond, and S. Khadabadi, Hepatoprotective activity of Ficus carica leaf extract on rifampicin-induced hepatic damage in rats. Indian J Pharm Sci 70 (2008) 364-6 |
[38] | A. Belfield, and D.M. Goldberg, Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine. Enzyme 12 (1971) 561-73 |
[39] | L. Jendrassik, and P. Grof, Biochem. J 297 (1938) 81 |
[40] | P. J. Bosma, J. R. Chowdhury, C. Bakker, S. Gantla, A. de Boer, B. A. Oostra, D. Lindhout, G. N. Tytgat, P. L. Jansen, R. P. Oude Elferink, and et al., The genetic basis of the reduced expression of bilirubin UDP-glucuronosyl- transferase 1 in Gilbert's syndrome. N Engl J Med 333 (1995) 1171-5 |
[41] | E. W. Gold, A simple spectrophotometric method for estimating glycosaminoglycan concentrations. Anal Biochem 99 (1979) 183-8. |
[42] | N. J. Jacobs, and P. J. Vandemark, The purification and properties of the alpha-glycerophosphate-oxidizing enzyme of Streptococcus faecalis 10C1. Arch Biochem Biophys 88 (1960) 250-5. |
[43] | P. Trinder, Enzymatic Calorimetric Test Clin. Biochem. J 6 (1969) 24-27. |
[44] | N. W. Tietz, Textbook of Clinical Chemistry. W. B. Saunders CO Philadelphia (1999) |
[45] | D. S. Young, Effect of Drugs on Clinical Lab Test. 5th Ed. AACC press (2000) |
[46] | G. I. Abelev, Alpha-fetoprotein as a marker of embryo-specific differentiations in normal and tumor tissues. Transplant Rev 20 (1974) 3-37 |
[47] | D. W. Chan, and Y. C. Miao, Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients. Clin Chem 32 (1986) 2143-6 |
[48] | M. Uotila, E. Ruoslahti, and E. Engvall, Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alpha-fetoprotein. J Immunol Methods 42 (1981) 11-5 |
[49] | Y. Kuang, N. Salem, F. Wang, S. J. Schomisch, V. Chandramouli, and Z. Lee, A colorimetric assay method to measure acetyl-CoA synthetase activity: application to woodchuck model of hepatitis virus-induced hepatocellular carcinoma. J Biochem Biophys Methods 70 (2007) 649-55 |
[50] | M. C. Kew, Serum aminotransferase concentration as evidence of hepatocellular damage. Lancet 355 (2000) 591-2 |
[51] | T. W. Leung, A. M. Tang, B. Zee, S. C. Yu, P. B. Lai, W. Y. Lau, and P. J. Johnson, Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy. Cancer 94 (2002) 421-7 |
[52] | D. V. Gopal, and H. R. Rosen, Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med 107 (2000) 100-2, 105-9, 113-4 |
[53] | W. Yeo, F. K. Mo, J. Koh, A. T. Chan, T. Leung, P. Hui, L. Chan, A. Tang, J. J. Lee, T. S. Mok, P. B. Lai, P. J. Johnson, and B. Zee, Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol 17 (2006) 1083-9 |
[54] | W. Yeo, T. S. Mok, B. Zee, T. W. Leung, P. B. Lai, W. Y. Lau, J. Koh, F. K. Mo, S. C. Yu, A. T. Chan, P. Hui, B. Ma, K. C. Lam, W. M. Ho, H. T. Wong, A. Tang, and P. J. Johnson, A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst 97 (2005) 1532-8 |
[55] | G. Zhang, Y. Miura, and K. Yagasaki, Effects of dietary powdered green tea and theanine on tumor growth and endogenous hyperlipidemia in hepatoma-bearing rats. Biosci Biotechnol Biochem 66 (2002) 711-6 |
[56] | G. Muralikrishnan, V. Amalan Stanley, and K. Sadasivan Pillai, Dual role of vitamin C on lipid profile and combined application of cyclophosphamide, methotrexate and 5-fluorouracil treatment in fibrosarcoma-bearing rats. Cancer Lett 169 (2001) 115-20 |
[57] | S. Subramaniam, S. Subramaniam, and C. S. Shyamala Devi, Erythrocyte antioxidant enzyme activity in CMF treated breast cancer patients. Cancer Biochem Biophys 14 (1994) 177-82 |
[58] | S. Acin, M. A. Navarro, J. S. Perona, J. M. Arbones-Mainar, J. C. Surra, M. A. Guzman, R. Carnicer, C. Arnal, I. Orman, J. C. Segovia, J. Osada, and V. Ruiz-Gutierrez, Olive oil preparation determines the atherosclerotic protection in apolipoprotein E knockout mice. J Nutr Biochem 18 (2007) 418-24 |
[59] | M. Kawasaki, R. Funabiki, and K. Yagasaki, Effects of dietary methionine and cystine on lipid metabolism in hepatoma-bearing rats with hyperlipidemia. Lipids 33 (1998) 905-11 |
[60] | G. W. Yip, M. Smollich, and M. Gotte, Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther 5 (2006) 2139-48 |
[61] | S. S. Skandalis, M. Stylianou, D. H. Vynios, N. Papageorgakopoulou, and D. A. Theocharis, The structural and compositional changes of glycosaminoglycans are closely associated with tissue type in human laryngeal cancer. Biochimie 89 (2007) 1573-80 |
[62] | L. X. Qin, and Z. Y. Tang, Metastasis and Recurrence after Surgical Resection of Hepatocellular Recent Progress in Clinical and Related Basic Aspects Carcinoma. Current Cancer Therapy Reviews 1 (2005) 71-80 |
[63] | L. P. Borges, V. C. Borges, A. V. Moro, C. W. Nogueira, J. B. Rocha, and G. Zeni, Protective effect of diphenyl diselenide on acute liver damage induced by 2-nitropropane in rats. Toxicology 210 (2005) 1-8 |
[64] | B. Premalatha, and P. Sachdanandam, Effect of Semecarpus Anacardium Nut Milk Extract on Rat Serum Alpha-Fetoprotein Level in Aflatoxin B -Mediated Hepatocellular Carcinoma. Fitoterapia 70 (1999) 279-283 |
[65] | N. Yahagi, H. Shimano, K. Hasegawa, K. Ohashi, T. Matsuzaka, Y. Najima, M. Sekiya, S. Tomita, H. Okazaki, Y. Tamura, Y. Iizuka, K. Ohashi, R. Nagai, S. Ishibashi, T. Kadowaki, M. Makuuchi, S. Ohnishi, J. Osuga, and N. Yamada, Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer 41 (2005) 1316-22 |
[66] | C. Peraino, E. F. Staffeldt, and V. A. Ludeman, Early appearance of histochemically altered hepatocyte foci and liver tumors in female rats treated with carcinogens one day after birth. Carcinogenesis 2 (1981) 463-5 |